Who It Is For Patients with stubborn visceral fat that resists diet and exercise Men and women experiencing metabolic slowdown associated with aging Patients with insulin resistance or metabolic syndrome who want to improve metabolic markers Anyone seeking meaningful body recomposition not just weight loss, but shifting the ratio of fat to lean mass Patients who have plateaued on a weight loss program and need a metabolic reset What to Expect Weeks 1-4: Improved energy and exercise tolerance as mitochondrial function improves
What may differ from younger patients: The rate of loss may be somewhat slower due to lower baseline metabolic rate and reduced hormonal support for fat mobilization
These relationships with obesity severity in patients with HFpEF were again observed in the present analysis, supporting the validity and generalizability of these data from the STEP-HFpEF trial
Clinical data from the SURMOUNT-4 trial, which examined weight regain after stopping tirzepatide, showed that approximately 60% of lost weight returned within one year of discontinuation, emphasizing the importance of ongoing treatment for sustained results
They may prescribe you another medication to help relieve your symptoms (like an antiemetic if youre vomiting a lot), or they may want to lower your dose or switch you to another GLP-1 with a lower risk of headache
